TY - JOUR
T1 - Ankle-brachial index measured by oscillometry is predictive for cardiovascular disease and premature death in the Japanese population
T2 - An individual participant data meta-analysis
AU - collaborative group for the Japan Brachial-Ankle pulse wave VELocity individual participant data meta-analysis of prospective studies to examine the significance of the Ankle-Brachial Index (J-BAVEL-ABI)
AU - Ohkuma, Toshiaki
AU - Ninomiya, Toshiharu
AU - Tomiyama, Hirofumi
AU - Kario, Kazuomi
AU - Hoshide, Satoshi
AU - Kita, Yoshikuni
AU - Inoguchi, Toyoshi
AU - Maeda, Yasutaka
AU - Kohara, Katsuhiko
AU - Tabara, Yasuharu
AU - Nakamura, Motoyuki
AU - Ohkubo, Takayoshi
AU - Watada, Hirotaka
AU - Munakata, Masanori
AU - Ohishi, Mitsuru
AU - Ito, Norihisa
AU - Nakamura, Michinari
AU - Shoji, Tetsuo
AU - Vlachopoulos, Charalambos
AU - Aboyans, Victor
AU - Yamashina, Akira
N1 - Funding Information:
This study was supported by Omron Health Care Company (Kyoto, Japan) , which awarded a grant to the baPWV IPD meta-analysis study group.
Funding Information:
Hirofumi Tomiyama had a grant donated from Omrom Health Care Company , and this study was conducted based on this grant. Yoshikuni Kita reports grants from Japan Society for the Promotion of Science /Japan, grants from Japan Arteriosclerosis Prevention Fund /Japan, during the conduct of the study. Takayoshi Ohkubo reports grants from Omron Healthcare , during the conduct of the study.
Publisher Copyright:
© 2018 Elsevier B.V.
PY - 2018/8
Y1 - 2018/8
N2 - Background and aims: The ankle–brachial index (ABI) is a predictor of cardiovascular disease (CVD) and premature death. However, few studies on this marker are available in the general Asian populations. This study aimed to investigate the association between ABI measured with oscillometry and the risk of these outcomes. Methods: We conducted an individual participant data meta-analysis in 10,679 community-dwelling Japanese individuals without a history of CVD. The primary outcome was a composite of CVD events and all-cause mortality. Results: During an average of 7.8 years of follow-up, 720 participants experienced the primary outcome. The multivariable-adjusted hazard ratios (HRs) of the primary outcome significantly increased with a lower ABI. The HRs were 1.07 (95% confidence interval [CI] 0.91–1.27) for ABI of 1.00–1.09, HR 1.37 (95% CI 1.04–1.81) for ABI of 0.91–0.99, and HR 1.60 (95% CI 1.06–2.41) for ABI of ≤0.90, compared with ABI of 1.10–1.19. Furthermore, a high ABI (≥1.30) was associated with a greater risk of outcome (HR 2.42 [95% CI 1.14–5.13]). Similar tendencies were observed for CVD events alone and all-cause mortality alone. Addition of ABI to a model with the Framingham risk score marginally improved the c-statistics (p = 0.08) and integrated discrimination improvement (p < 0.05) for the primary outcome. Conclusions: The present study suggests that lower and higher ABI are significantly associated with an increased risk of CVD and all-cause mortality in the Japanese population. The ABI, which is easily measured by oscillometry, may be incorporated into daily clinical practice to identify high-risk populations.
AB - Background and aims: The ankle–brachial index (ABI) is a predictor of cardiovascular disease (CVD) and premature death. However, few studies on this marker are available in the general Asian populations. This study aimed to investigate the association between ABI measured with oscillometry and the risk of these outcomes. Methods: We conducted an individual participant data meta-analysis in 10,679 community-dwelling Japanese individuals without a history of CVD. The primary outcome was a composite of CVD events and all-cause mortality. Results: During an average of 7.8 years of follow-up, 720 participants experienced the primary outcome. The multivariable-adjusted hazard ratios (HRs) of the primary outcome significantly increased with a lower ABI. The HRs were 1.07 (95% confidence interval [CI] 0.91–1.27) for ABI of 1.00–1.09, HR 1.37 (95% CI 1.04–1.81) for ABI of 0.91–0.99, and HR 1.60 (95% CI 1.06–2.41) for ABI of ≤0.90, compared with ABI of 1.10–1.19. Furthermore, a high ABI (≥1.30) was associated with a greater risk of outcome (HR 2.42 [95% CI 1.14–5.13]). Similar tendencies were observed for CVD events alone and all-cause mortality alone. Addition of ABI to a model with the Framingham risk score marginally improved the c-statistics (p = 0.08) and integrated discrimination improvement (p < 0.05) for the primary outcome. Conclusions: The present study suggests that lower and higher ABI are significantly associated with an increased risk of CVD and all-cause mortality in the Japanese population. The ABI, which is easily measured by oscillometry, may be incorporated into daily clinical practice to identify high-risk populations.
UR - http://www.scopus.com/inward/record.url?scp=85048256027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048256027&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2018.05.048
DO - 10.1016/j.atherosclerosis.2018.05.048
M3 - Article
C2 - 29902702
AN - SCOPUS:85048256027
SN - 0021-9150
VL - 275
SP - 141
EP - 148
JO - Atherosclerosis
JF - Atherosclerosis
ER -